Acetyl Hexapeptide-8, commercially known as Argireline, is a synthetic hexapeptide that mimics the N-terminal end of SNAP-25, a protein essential for neurotransmitter release at neuromuscular junctions. By competing with SNAP-25 in the SNARE complex, Argireline reduces the release of neurotransmitters that cause facial muscle contraction, thereby diminishing expression lines and wrinkles. Often marketed as 'Botox in a jar,' clinical studies demonstrate up to 30% wrinkle depth reduction after 30 days of topical application. Argireline is one of the most commercially successful cosmetic peptides globally. We supply it in pharmaceutical-grade bulk quantities for cosmetic formulation houses and contract manufacturers.
| Sequence | Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2 |
| Molecular Weight | 888.96 g/mol |
| Purity | ≥95% (HPLC) |
| Form | Powder / Solution |
| Storage | 2-8°C |
| CAS | 616204-22-9 |
| INCI | Acetyl Hexapeptide-8 |
Neurocosmetic hexapeptide for expression line reduction — the 'topical alternative to botulinum toxin' for anti-wrinkle formulations.
We supply Acetyl Hexapeptide-8 (Argireline) at ≥95% (HPLC) purity. Higher purity grades are available for pharmaceutical applications upon request.
Minimum order quantities for wholesale Acetyl Hexapeptide-8 (Argireline) depend on the quantity and purity grade required. Contact our sales team for specific pricing and MOQ information.
Acetyl Hexapeptide-8 (Argireline) should be stored at 2-8°C in a desiccated environment. Proper cold-chain shipping is maintained for all deliveries.
Copper-binding tripeptide with clinically proven anti-aging, wound healing, and hair growth stimulat...
View Details Cosmetic PeptidesSynthetic analog of alpha-melanocyte stimulating hormone (α-MSH) for melanogenesis stimulation and t...
View Details Cosmetic PeptidesClinically proven cosmetic peptide for collagen stimulation, wrinkle reduction, and skin rejuvenatio...
View Details Cosmetic PeptidesAdvanced octapeptide extending Argireline's mechanism for enhanced expression line smoothing in next...
View Details